Disorders of movement : clinical, pharmacological and physiological aspects
Author(s)
Bibliographic Information
Disorders of movement : clinical, pharmacological and physiological aspects
Academic Press, c1989
Available at / 6 libraries
-
No Libraries matched.
- Remove all filters.
Description and Table of Contents
Description
Professor David Marsden is a world authority on movement disorders. His past and present students and co-workers have produced this compilation of a wealth of knowledge, covering a wide range of motor disturbances, as a tribute to him.
Table of Contents
- Part 1 Parkinson's disease: is there a Parkinson's disease?
- organization of the basal ganglia
- the pathology of Parkinson's disease
- the pathophysiology of Parkinson's disease
- models of cognitive dysfunction in Parkinson's disease
- biochemistry of neurotransmitters in Parkinson's disease
- the neurochemistry of Parkinson's disease as revealed by PET scanning
- sleep and Parkinson's disease
- different therapeutic approaches to complicated Parkinson's disease
- the anti-Parkinsonian effects of transdermal (+)-PHONO -MPTP and its relevance to Parkinson's disease
- the role of dopamine in the selectivity of the neurotoxin MPTP for nigrostriatal dopamine neurons
- effects of dopamine D-1 and D-2 receptor stimulation in MPTP monkeys
- chronic infusions of dopamine agonists in animals
- delivery of (+)-4-propyl-9-hydroxy-naphthoxazine [(+)-PHNO] by a novel orally administered osmotic tablet - behavioural effect in animal models of Parkinson's disease
- studies towards neural transplantation in Parkinson's disease - dystonia - the pathophysiology of dystonia
- pathophysiology of cranial dystonia - a review
- positron emission tomographic investigations of dystonia
- blepharospasm - clinical aspects of their therapeutic considerations
- the treatment of spasmodic torticollis
- surgical treatment of spasmodic torticollis
- drug treatment of dystonia
- dopa-responsive dystonia - 20 years into the levodopa era
- the clinical use of botulinium toxin
- dystonia
- where next?. Part 2 Neuroleptic-induced movement disorders: neuroleptic-induced movement disorders
- the consequences of chronic exposure to neuroleptics in the rat
- experimental models of acute dystonia. Part 3 Other movement disorders: degenerative ataxic disorders
- the physiology of myoclonus in man
- experimental models of myoclonus
- the bio-chemistry of Huntington's chorea
- classification of tremor
- orthostatic tremor
- long-latency reflexes
- cortical stimulation in man. Part 4 Concluding Remarks: movement disorders
- the problem of definition.
by "Nielsen BookData"
